G6PD and neoplasm: Indeed, previous studies have reported that the combination of G6PD inhibitors with anti-tumor drugs, such as doxorubicin, 5-FU, and paclitaxel, can be a promising strategy in treating tumor and reversing chemotherapeutic resistance [24,144,145,147,148].